Himalaya Nutravedics IPO
Founded in 2022, Himalaya Nutravedics is an Ayurvedic and nutraceutical manufacturing firm involved in the formulation, manufacturing, and marketing of Ayurvedic and nutraceutical products. Its product portfolio includes Softgel Capsules, Tablets, Medicated Oils, Liquid Orals, Hardgel Capsules, and Protein Powders across therapeutic categories such as digestive health, immunity, metabolic health, and pain management.
IPO GMP
₹0
+0% expected gain
Price Band
₹100 - ₹106
Lot Size
2400 shares
Min Investment
₹2,54,400
Listing Date
September 29, 2026
About Himalaya Nutravedics
Company overview, business, and key facts.
Founded in 2022, Himalaya Nutravedics is an Ayurvedic and nutraceutical manufacturing firm involved in the formulation, manufacturing, and marketing of Ayurvedic and nutraceutical products. Its product portfolio includes Softgel Capsules, Tablets, Medicated Oils, Liquid Orals, Hardgel Capsules, and Protein Powders across therapeutic categories such as digestive health, immunity, metabolic health, and pain management.
The firm sells its products under its own brands and also sells them through doctors, hospitals, clinics, pharmacists, or other healthcare professionals. The firm has expanded its portfolio across 17 states and one union territory in India. Moreover, its manufacturing facility is located at is located in Hyderabad, Telangana, and holds WHO-GMP certifications. Its competitive strengths are strong relationships with suppliers and customers and Integrated multi-dosage manufacturing capability.
Founded
2022
Headquarters
Hyderabad, Telangana
Promoters
Rohit Asawa, Divya Asawa, Chanda Asawa, Rama Raju Penmatsas
Website
https://www.himalayanutravedics.com/
IPO Details
Subscription Status
How many times each investor category has bid for the issue.
Financials
Restated summary financials for the most recent periods.
Figures are indicative and restated for presentation.
Himalaya Nutravedics IPO Key Numbers
Calculated by IPOLyst from the published offer-document data. These are figures, not buy or sell calls.
Market cap at upper band
₹93.3 Cr
Post-IPO shares × upper price band
P/E on 2026 profit
12.6x
Peer median 63.7x (discount of 80.2%)
Price to sales
2.16x
Revenue growth, 2026
+105.3%
72.9% a year over the period
Profit growth, 2026
+231.4%
314.6% a year over the period
Profit margin (PAT)
17.1%
EBITDA margin 18.82%
ROE / ROCE
63.87% / 36.41%
As published in the offer document
Debt to equity
0.31
Promoter holding
95.14% → 68.13%
Before → after the IPO
Issue mix
100% fresh / 0% sale
Fresh issue goes to the company, offer for sale to selling shareholders
GMP-implied gain per lot
₹0
2400 shares on ₹2,54,400. GMP is unofficial.
What stands out
- Healthy profit margin: PAT margin was 17.1% in 2026.
- Profit grew 231.4% in 2026.
- Priced at a 80.2% discount to the peer median P/E of 63.7.
Watch-outs
- 1 use-of-proceeds item(s) have no disclosed amount.
Scenarios apply today's grey market premium figures to the upper price band. They are illustrations, not predictions. GMP is unofficial and can be wrong.
Not yet available for this IPO: published risk factors.
IPO Analysis SummaryAI-generated
A plain-language review of Himalaya Nutravedics's financials, valuation and demand, based only on the verified figures above. For information only. It does not recommend whether to apply.
Himalaya Nutravedics IPO Review
Analysis based on live GMP, subscription, and issue details.
Himalaya Nutravedics IPO is currently showing a neutral GMP of ₹0, suggesting the market is cautious about listing gains.
The IPO has been subscribed 2.21x overall — QIB: 1x, NII: 2.83x, Retail: 2.54x.
Himalaya Nutravedics IPO subscription has closed. The shares are expected to list on September 29, 2026.
The minimum investment required is ₹2,54,400 for 2400 shares (1 lot). Retail investors can apply at cut-off price for the best chance of allotment.
Disclaimer: IPO GMP is indicative and sourced from the grey market. This is not investment advice. Please consult a SEBI-registered advisor before investing.
Himalaya Nutravedics IPO — Frequently Asked Questions
What is Himalaya Nutravedics IPO GMP today?
Himalaya Nutravedics IPO GMP (grey market premium) today is ₹0, suggesting an estimated listing gain of +0%. GMP is indicative and subject to change.
What is the price band of Himalaya Nutravedics IPO?
The price band for Himalaya Nutravedics IPO is ₹100 - ₹106 with a lot size of 2400 shares. The minimum investment required is ₹2,54,400.
When is Himalaya Nutravedics IPO allotment date?
Himalaya Nutravedics IPO allotment is expected to be finalised on September 25, 2026. You can check your allotment status on the registrar's website (Kfin Technologies Ltd.) using your PAN number.
When will Himalaya Nutravedics IPO list on NSE/BSE?
Himalaya Nutravedics IPO is expected to list on BSE SME on September 29, 2026.
How to check Himalaya Nutravedics IPO allotment status?
To check Himalaya Nutravedics IPO allotment status, visit the registrar's website (Kfin Technologies Ltd.) and enter your PAN number, application number, or DP/Client ID. You can also check on the BSE IPO allotment page at https://www.bseindia.com/investors/appli_check.aspx.
Should I apply for Himalaya Nutravedics IPO?
Himalaya Nutravedics IPO has a GMP of ₹0. Before applying, review the company's financials, business model, issue structure (OFS vs fresh issue), and sector outlook. IPOLyst is not a SEBI-registered investment advisor — please consult a qualified financial advisor before investing.
What is the lot size of Himalaya Nutravedics IPO?
The lot size for Himalaya Nutravedics IPO is 2400 shares per lot. The minimum investment for retail investors is ₹2,54,400. Retail investors can apply for a maximum of 13 lots or up to ₹2 lakh, whichever is lower.